Immunohistochemical distribution of laminin-332 and collagen type IV in the basement membrane of normal horses and horses with induced laminitis.

This research article investigates the effect of equine laminitis on proteins found in the basement membranes of different organs in horses. More specifically, the study explores how the disease impacts the distribution of laminin-332 and collagen type IV, two proteins significant in the structure of the basement membrane.

Understanding the Basement Membrane

• The basement membrane (BM) is a thin layer that lies in the extracellular matrix, a complex structure that exists outside of cells that offers support for cells and regulates their functions.
• The primary components of the basement membrane in epithelial tissues are laminin-332 and collagen type IV. These two proteins play significant roles in maintaining the proper structure and functions of tissues within the body.

Equine Laminitis and its Effects

• Equine laminitis is a disease common in horses. This disorder is characterized by the breakdown and displacement of the hoof lamellar basement membrane, causing immense pain and potentially severe mobility issues for the affected horse.
• The study examined different tissues in normal and experimentally laminitic horses through the application of immunohistochemistry, a technique that visualizes proteins in tissues by staining them with specific antibodies.

Findings and Implications

• The results revealed that in normal horses, laminin-332 and collagen type IV are widely distributed in different organs. However, in horses with induced laminitis, the levels of these proteins degrade not only in the hoof lamellae, but also in other epithelial tissues, such as the skin and stomach.
• This implies that the degradation of the basement membrane is a systemic effect of equine laminitis, affecting various parts of the horse’s body.
• The findings propose that systemic trigger factors could be involved in the progression of equine laminitis. This opens up avenues for further research into the disease’s causes and potential therapeutic targets.